Vandetanib Experience in a Patient With Ectopic Cushing Syndrome in Metastatic Medullary Thyroid Cancer

Turkish Journal of Endocrinology and Metabolism - Turkey
doi 10.25179/tjem.20182202-p188
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Turkish Journal of Endocrinology and Metabolism

Related search

Tale of Two Endocrine Organs: Medullary Thyroid Carcinoma (MTC) With Ectopic Cushing Syndrome

Surgery: Current Research
2014English

Evaluating Vandetanib in the Treatment of Medullary Thyroid Cancer: Patient-Reported Outcomes

Cancer Management and Research
Oncology
2019English

Ectopic Production of Parathyroid Hormone in a Patient With Sporadic Medullary Thyroid Cancer

Endocrine Journal
EndocrinologyMetabolismDiabetes
2010English

Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2012English

Predictive Value of FDG-PET in Patients With Advanced Medullary Thyroid Carcinoma Treated With Vandetanib

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2017English

Thyroid Medullary Carcinoma in a Patient With HIV/AIDS

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi
OncologyHematology
2012English

An Endocrine Picture in Disguise: A Progressive Olfactory Neuroblastoma Complicated With Ectopic Cushing Syndrome

AACE Clinical Case Reports
2017English

Cabozantinib in Progressive Medullary Thyroid Cancer

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2013English

A Dog Pedigree With Familial Medullary Thyroid Cancer

International Journal of Oncology
Cancer ResearchOncology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy